Former Wisconsin Rep. Mike Gallagher joined 'America's Newsroom' to discuss Trump's tariff threat against China and his ...
Eli Lilly & Co (LLY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Mohit ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Eli Lilly And Co (NYSE:LLY) shares are trading higher Tuesday after the Biden-Harris Administration proposed a new rule to ...
GlobalData on MSN17h
MHRA approves Eli Lilly’s Alzheimer’s diagnostic imaging agent TauvidThe UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Tauvid (flortaucipir), a diagnostic imaging ...
The Health Resources and Services Administration has “invoked the nuclear option of removal from not only the 340B program ...
The Motley Fool on MSN8d
Is It Time to Sell Eli Lilly and Pfizer Stocks?Pfizer also made a fortune with its oral COVID-19 therapy, Paxlovid. Eli Lilly now ranks as the largest drugmaker in the ...
Eli Lilly and Company chief corporate brand officer Lina Polimeni described the new format as a “big evolution” in the company’s marketing, shifting its focus to the Lilly brand, its patients and an ...
Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead ...
Shares of General Motors and Ford fall after President-elect Donald Trump announces his tariff plans, while Amgen tumbles as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback